MAC vs SRPT · rev $918.2M vs rev $1.90B
Macerich Company (MAC) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Macerich Company (MAC) is a reit - retail company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported MAC revenue for 2024-12-31 was $918.2M. Net income was -$197.7M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. MAC currently screens at market cap $4.41B.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
MAC currently screens at market cap $4.41B. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the MAC and SRPT stock pages for the full models.
Not investment advice.